Researchers Develop New Method for Sexing Sperm

Scientists found they could sort mouse sperm prior to IVF by treating semen with a drug that selectively slows down X-bearing cells.

Written byKatarina Zimmer
| 4 min read
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The mammalian X chromosome has many genes that the Y does not—a feature that has special implications for sperm, and also for scientists.

The mouse X chromosome carries two protein receptors that when activated by a chemical make X-bearing sperm slower and easy to separate from Y-bearing sperm, a team of Japanese researchers has found. By sorting the gametes using this method and allowing them to fertilize oocytes in vitro, the scientists could selectively generate mouse litters with majority-female or majority-male pups, they report today (August 13) in PLOS Biology.

“It’s definitely an excellent piece of work,” remarks James Knight, a reproductive biologist at Virginia Tech who wasn’t involved in the study. “The whole methodology that they’re describing, given the accuracy of separating X- and Y-bearing sperm, has tremendous applicability to several species.”

Reproductive biologist Masayuki Shimada of Hiroshima University and his colleagues initially began the research to better understand ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies